Free Trial
LON:TRX

Tissue Regenix Group (TRX) Share Price, News & Analysis

Tissue Regenix Group logo
GBX 29.80 +0.80 (+2.76%)
As of 11:35 AM Eastern

About Tissue Regenix Group Stock (LON:TRX)

Key Stats

Today's Range
28.75
29.80
50-Day Range
25
39.52
52-Week Range
25
67
Volume
13,550 shs
Average Volume
55,356 shs
Market Capitalization
£26.87 million
P/E Ratio
N/A
Dividend Yield
4.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tissue Regenix Group and its competitors with MarketBeat's FREE daily newsletter.

TRX Stock News Headlines

Tissue Regenix Scraps Sale Plans, Flags Profit Ahead
The stealth altcoin the financial world is underestimating
This DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening RIGHT NOW—this project is poised to see massive moves.... The smart money is already positioning.tc pixel
Tissue Regenix Group Regulatory News
Tissue Regenix Group Share Chat (TRX)
Tissue Regenix Group PLC (LSW.BE)
See More Headlines

TRX Stock Analysis - Frequently Asked Questions

Tissue Regenix Group's stock was trading at GBX 60 at the beginning of the year. Since then, TRX stock has decreased by 50.3% and is now trading at GBX 29.80.

Tissue Regenix Group plc (LON:TRX) posted its quarterly earnings data on Wednesday, September, 2nd. The company reported ($0.16) earnings per share for the quarter. Tissue Regenix Group had a negative trailing twelve-month return on equity of 2.87% and a negative net margin of 3.46%.

Shares of TRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tissue Regenix Group investors own include Lloyds Banking Group (LLOY), Argos Therapeutics (ARGSQ), FuelCell Energy (FCEL), TransEnterix (TRXDW), Swedbank (SWDBY), Trevena (TRVN) and Barrick Gold (ABX).

Company Calendar

Last Earnings
9/02/2020
Today
8/22/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Precious Metals
Current Symbol
LON:TRX
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
57.25
P/E Growth
N/A
Net Income
-£1.11 million
Net Margins
-3.46%
Pretax Margin
N/A
Return on Equity
-2.87%
Return on Assets
0.50%

Debt

Debt-to-Equity Ratio
31.16
Current Ratio
4.03
Quick Ratio
2.36

Sales & Book Value

Annual Sales
£31.98 million
Price / Sales
0.81
Cash Flow
GBX 5.04 per share
Price / Cash Flow
5.70
Book Value
GBX 41.58 per share
Price / Book
0.69

Miscellaneous

Outstanding Shares
90,155,317
Free Float
N/A
Market Cap
£25.92 million
Optionable
Not Optionable
Beta
1.61
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (LON:TRX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners